{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:26:17Z","timestamp":1777685177379,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2020,2,10]]},"DOI":"10.3233\/jhd-190389","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:34:44Z","timestamp":1580229284000},"page":"13-31","source":"Crossref","is-referenced-by-count":2,"title":["Transcriptional Assessment of Striatal mRNAs as Valid Biomarkers of Disease Progression in Three Mouse Models of Huntington\u2019s Disease"],"prefix":"10.1177","volume":"9","author":[{"given":"Afshin","family":"Ghavami","sequence":"first","affiliation":[{"name":"PsychoGenics Inc., Paramus, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Olsen","sequence":"additional","affiliation":[{"name":"PsychoGenics Inc., Paramus, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Kwan","sequence":"additional","affiliation":[{"name":"PsychoGenics Inc., Paramus, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Beltran","sequence":"additional","affiliation":[{"name":"PsychoGenics Inc., Paramus, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Shea","sequence":"additional","affiliation":[{"name":"PsychoGenics Inc., Paramus, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Ramboz","sequence":"additional","affiliation":[{"name":"PsychoGenics Inc., Paramus, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhen","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Lavery","sequence":"additional","affiliation":[{"name":"CHDI Management\/CHDI Foundation, Inc, Princeton, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Howland","sequence":"additional","affiliation":[{"name":"CHDI Management\/CHDI Foundation, Inc, Princeton, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry C.","family":"Park","sequence":"additional","affiliation":[{"name":"CHDI Management\/CHDI Foundation, Inc, Princeton, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"5","key":"10.3233\/JHD-190389_ref1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005792-199709000-00001","article-title":"Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA)","volume":"76","author":"Ross","year":"1997","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.3233\/JHD-190389_ref2","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","article-title":"Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription","volume":"277","author":"Kegel","year":"2002","journal-title":"J Biol Chem"},{"issue":"17","key":"10.3233\/JHD-190389_ref3","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: Parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.3233\/JHD-190389_ref4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","article-title":"Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington\u2019s disease and related disorders","volume":"35","author":"Ross","year":"2002","journal-title":"Neuron"},{"issue":"4","key":"10.3233\/JHD-190389_ref5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington\u2019s disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog Neurobiol"},{"issue":"15","key":"10.3233\/JHD-190389_ref6","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.3233\/JHD-190389_ref7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/pro.5560031002","article-title":"Polar zippers: Their role in human disease","volume":"3","author":"Perutz","year":"1994","journal-title":"Protein Sci"},{"issue":"6","key":"10.3233\/JHD-190389_ref8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0959-440X(96)80016-9","article-title":"Glutamine repeats and inherited neurodegenerative diseases: Molecular aspects","volume":"6","author":"Perutz","year":"1996","journal-title":"Curr Opin Struct Biol"},{"issue":"5","key":"10.3233\/JHD-190389_ref9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"9","key":"10.3233\/JHD-190389_ref10","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.3233\/JHD-190389_ref11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"issue":"8","key":"10.3233\/JHD-190389_ref12","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J Neurosci"},{"issue":"12","key":"10.3233\/JHD-190389_ref13","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.3233\/JHD-190389_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.06.005","article-title":"Rodent genetic models of Huntington disease","volume":"32","author":"Heng","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.3233\/JHD-190389_ref15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.3233\/JHD-190389_ref16","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-190389_ref17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-12-385883-2.00010-2","article-title":"Huntington disease and the huntingtin protein","volume":"107","author":"Zheng","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/JHD-190389_ref18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-3-17","article-title":"Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington\u2019s disease","volume":"3","author":"Benn","year":"2008","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10.3233\/JHD-190389_ref19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410250315","article-title":"An immunohistochemical investigation of the human neostriatum in Huntington\u2019s disease","volume":"25","author":"Goto","year":"1989","journal-title":"Ann Neurol"},{"issue":"8597","key":"10.3233\/JHD-190389_ref20","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(88)92073-9","article-title":"Loss of matrix calcium-binding protein-containing neurons in Huntington\u2019s disease","volume":"1","author":"Seto-Ohshima","year":"1988","journal-title":"Lancet"},{"issue":"1","key":"10.3233\/JHD-190389_ref21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington\u2019s disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann Neurol"},{"issue":"3","key":"10.3233\/JHD-190389_ref22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia nigra in Huntington\u2019s disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"issue":"4","key":"10.3233\/JHD-190389_ref23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.410300406","article-title":"Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington\u2019s disease: An in situ hybridization study","volume":"30","author":"Albin","year":"1991","journal-title":"Ann Neurol"},{"key":"10.3233\/JHD-190389_ref24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington\u2019s disease: Time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"issue":"4","key":"10.3233\/JHD-190389_ref25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0306-4522(95)00596-X","article-title":"Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington\u2019s disease","volume":"72","author":"Norris","year":"1996","journal-title":"Neuroscience"},{"issue":"4","key":"10.3233\/JHD-190389_ref26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neures.2008.08.007","article-title":"The fate of the large striatal interneurons expressing calretinin in Huntington\u2019s disease","volume":"62","author":"Massouh","year":"2008","journal-title":"Neurosci Res"},{"key":"10.3233\/JHD-190389_ref27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","article-title":"Microglial physiology: Unique stimuli, specialized responses","volume":"27","author":"Ransohoff","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"3-4","key":"10.3233\/JHD-190389_ref28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1023\/B:MEBR.0000043984.73063.d8","article-title":"Microglia","volume":"19","author":"van Rossum","year":"2004","journal-title":"Metab Brain Dis"},{"issue":"11","key":"10.3233\/JHD-190389_ref29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: A clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"issue":"2-3","key":"10.3233\/JHD-190389_ref30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","article-title":"Imaging microglial activation in Huntington\u2019s disease","volume":"72","author":"Tai","year":"2007","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.3233\/JHD-190389_ref31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/157488906775245273","article-title":"The astrocytic GABA(A)\/benzodiazepine-like receptor: The Joker receptor for benzodiazepine-mimetic drugs?","volume":"1","author":"Hertz","year":"2006","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"5","key":"10.3233\/JHD-190389_ref32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/08916930600739605","article-title":"The complement system in central nervous system diseases","volume":"39","author":"Rus","year":"2006","journal-title":"Autoimmunity"},{"issue":"5","key":"10.3233\/JHD-190389_ref33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.molimm.2006.03.007","article-title":"Role of complement in neurodegeneration and neuroinflammation","volume":"44","author":"Bonifati","year":"2007","journal-title":"Mol Immunol"},{"issue":"1-2","key":"10.3233\/JHD-190389_ref34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"issue":"2","key":"10.3233\/JHD-190389_ref35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp Neurol"},{"issue":"8","key":"10.3233\/JHD-190389_ref36","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"10.3233\/JHD-190389_ref37","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J Proteome Res"},{"issue":"50","key":"10.3233\/JHD-190389_ref38","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","article-title":"Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington\u2019s disease","volume":"32","author":"Bouchard","year":"2012","journal-title":"J Neurosci"},{"issue":"3","key":"10.3233\/JHD-190389_ref39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington\u2019s disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem Res"},{"issue":"1","key":"10.3233\/JHD-190389_ref40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JHD-190389_ref41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse","volume":"47","author":"Tabrizi","year":"2000","journal-title":"Ann Neurol"},{"issue":"5","key":"10.3233\/JHD-190389_ref42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.3233\/JHD-190389_ref43","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: A model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol Cell Proteomics"},{"issue":"9","key":"10.3233\/JHD-190389_ref44","doi-asserted-by":"crossref","first-page":"e46492","DOI":"10.1371\/journal.pone.0046492","article-title":"Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington\u2019s disease patients","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.3233\/JHD-190389_ref45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr Rev"},{"issue":"1","key":"10.3233\/JHD-190389_ref46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"issue":"35","key":"10.3233\/JHD-190389_ref47","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.2174\/138161282035140911142118","article-title":"Mitochondrial biogenesis: Pharmacological approaches","volume":"20","author":"Valero","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"9","key":"10.3233\/JHD-190389_ref48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington\u2019s disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosci"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-190389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:59Z","timestamp":1777452659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-190389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":48,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jhd-190389","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]}}}